These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 25779011

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system.
    Liu H, Zhang J, Wang S, Pang Z, Wang Z, Zhou W, Wu M.
    Cancer Epidemiol; 2012 Feb; 36(1):82-8. PubMed ID: 22018955
    [Abstract] [Full Text] [Related]

  • 25. Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma.
    Lu F, Shah PA, Rao A, Gifford-Hollingsworth C, Chen A, Trey G, Soryal M, Talat A, Aslam A, Nasir B, Choudhry S, Ishtiaq R, Sanoff H, Conteh LF, Noonan A, Hu KQ, Schmidt C, Fu M, Civan J, Xiao G, Lau DT, Lu X.
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00271. PubMed ID: 33512798
    [Abstract] [Full Text] [Related]

  • 26. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X, Cheng M, Si Y, Wang M, Zhong J, Niu J, Yang W.
    PLoS One; 2015 Dec; 10(5):e0127518. PubMed ID: 25996938
    [Abstract] [Full Text] [Related]

  • 27. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
    Cao B, Yang L, Rong W, Feng L, Han N, Zhang K, Cheng S, Wu J, Xiao T, Gao Y.
    Int J Clin Exp Pathol; 2015 Dec; 8(12):16046-54. PubMed ID: 26884881
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma.
    Wu CS, Yen CJ, Chou RH, Li ST, Huang WC, Ren CT, Wu CY, Yu YL.
    PLoS One; 2012 Dec; 7(7):e39466. PubMed ID: 22808038
    [Abstract] [Full Text] [Related]

  • 32. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q, Fan J, Yang XR, Tan Y, Zhao W, Xu Y, Wang N, Niu Y, Wu Z, Zhou J, Qiu SJ, Shi YH, Yu B, Tang N, Chu W, Wang M, Wu J, Zhang Z, Yang S, Gu J, Wang H, Qin W.
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Morota K, Nakagawa M, Sekiya R, Hemken PM, Sokoll LJ, Elliott D, Chan DW, Dowell BL.
    Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
    [Abstract] [Full Text] [Related]

  • 35. An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma.
    Hong Y, Long J, Li H, Chen S, Liu Q, Zhang B, He X, Wang Y, Li H, Li Y, Zhang T, Lu C, Yan H, Zhang M, Li Q, Cao B, Bai Z, Wang J, Zhang Z, Zhu S, Zheng J, Ou X, Ma H, Jia J, You H, Wang S, Huang J.
    EBioMedicine; 2015 May; 2(5):438-46. PubMed ID: 26137588
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography-mass spectrometry.
    Passos-Castilho AM, Carvalho VM, Cardozo KH, Kikuchi L, Chagas AL, Gomes-Gouvêa MS, Malta F, de Seixas-Santos Nastri AC, Pinho JR, Carrilho FJ, Granato CF.
    BMC Cancer; 2015 Dec 18; 15():985. PubMed ID: 26680993
    [Abstract] [Full Text] [Related]

  • 40. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
    Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, Stadheim LM, Aderca I, Moser CD, Nagorney DM, LaRusso NF, de Groen PC, Menon KV, Lazaridis KN, Gores GJ, Charlton MR, Roberts RO, Therneau TM, Katzmann JA, Roberts LR.
    Clin Gastroenterol Hepatol; 2007 Mar 18; 5(3):394-402; quiz 267. PubMed ID: 17368240
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.